您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (7): 88-90.doi: 10.6040/j.issn.1671-7554.0.2015.730

• • 上一篇    下一篇

米力农雾化治疗小儿重症肺炎合并心力衰竭的疗效

许天一1,吴萍1,王爱玲1,陈丽萍2   

  1. 1.济南市第四人民医院儿科, 山东 济南 250031;2.泰安市中心医院儿童内科, 山东 泰安 271000
  • 收稿日期:2015-08-04 出版日期:2016-07-10 发布日期:2016-07-10
  • 通讯作者: 陈丽萍. E-mail: clp8572@163.com E-mail:clp8572@163.com

Clinical effect of milrinone atomization inhalation on treating severe pneumonia complicated with heart failure of neonates and infants

XU Tianyi1, WU Ping1, WANG Ailing1, CHEN Liping2   

  1. 1. Department of Pediatrics, The Fourth Peoples Hospital of Jinan City, Jinan 250031, Shandong, China;
    2. Department of Pediatrics, Taian City Central Hospital, Taian 271000, Shandong, China
  • Received:2015-08-04 Online:2016-07-10 Published:2016-07-10

摘要: 目的 探讨米力农雾化治疗新生儿及小婴儿重症肺炎合并心力衰竭的疗效及安全性。 方法 选择240例重症肺炎合并心力衰竭的患儿,随机分为对照组和观察组,每组120例。对照组给予常规洋地黄、利尿等基础治疗;观察组在对照组的基础上加用米力农雾化。观察两组临床疗效和心功能指标的变化。 结果 治疗5 d后,两组中大部分患者的临床症状、体征及心功能指标均改善,观察组治疗前后各项观察指标的改善均优于对照组,两组治疗后临床疗效和心功能指标差值比较,差异有统计学意义(P<0.05)。 结论 在常规洋地黄、利尿等治疗基础上,米力农雾化能更快地减低肺循环阻力、减少心脏前负荷和后负荷,从而有效地改善患儿心功能。

关键词: 重症肺炎, 心力衰竭, 米力农雾化, 肺动脉高压

Abstract: Objective To discuss the curative effect and security of milrinone atomization inhalation on treating severe pneumonia complicated with heart failure in noenates and infants. Methods A total of 240 cases with severe pneumonia complicated with heart failure in the fourth Peoples Hospital of Jinan City from 2012 to 2015 were randomly divided into control group and observation group, 120 in each group. The control group was treated with digitalis, diuretic, and other conventional therapies; on this basis, the observation group was treated additionally with milrinone atomization inhalation. Changes of the clinical efficacy and cardiac function indexes of the two groups were observed. Results After 5 days of treatment, clinical symptoms, signs and cardiac function indexes were improved significantly in the two groups. The improvement of cardiac function indexes in the observation group was better than that in the control group. The difference of clinical efficacy and cardiac function indexes before and after the treatment in the two groups were statistically significant(P<0.05). Conclusion On the basis of routine treatment such as digitalis and diuretic therapy, milrinone atomization inhalation can reduce the pulmonary circulation resistance, cardiac preload and afterload, thus effectively improve the heart function in noenates and infants with severe pneumonia complicated with heart failure.

Key words: Severe pneumonia, Pulmonary artery hypertension, Milrinone atomization, Heart failure

中图分类号: 

  • R725.6
[1] 马登勋,王利东.米力农联合多巴胺治疗小儿肺炎合并心力衰竭[J]. 新乡医学院学报, 2012, 29(5):381-383. MA Dengxun, WANG Lidong. Milrinone combined with dopamine in the treatment in children with pneumonia complicated with heart failure[J]. Xinxiang Medical College Journal, 2012, 29(5):381-383.
[2] Kobayashi S, Susa T, Tanaka T, et al. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure[J]. Circ J, 2012, 76(7):1646-1653.
[3] 胡亚美, 江载芳.诸福棠实用儿科学[M]. 7 版. 北京: 人民卫生出版社, 2002: 1511-1525.
[4] Hentschel T, Yin N, Riad A, eI al. Inhalation of the phosphodies-terase-3 inhibitor milrinone attenuates pulmonary hypertension in an experimental model of congestive heart failure[J]. Anesthesiology, 2007, 106(1):124-131.
[5] 王耀菊. 米力农治疗小儿充血性心力衰竭疗效观察[J]. 中国实用儿科杂志, 2010, 22(11): 91-92. WANG Yaoju. Milrinone in the treatment of children with congestive heart failure curative effect observation[J]. Chinese Journal of Practical Pediatrics, 2010, 22(11):91-92.
[6] 孔令先. 米力农治疗顽固性心力衰竭的临床疗效及安全性分析[J]. 中国保健营养, 2013, 6(1):201-202. KONG Lingxian. Milrinone in treatment of refractory heart failure clinical efficacy and safety analysis[J]. China Health Nutrition, 2013, 6(1):201-202.
[7] Rieg AD, Suleiman S, Perez-Bouza A, et al. Milrinone relaxes plumonary veins in guinea pigs and humans[J]. PLoS One, 2014, 9(1):e876-885. doi: 10.1371/journal.pone.0087685.
[8] 冯永萌, 郭瑞霞, 张菲菲. 不同剂量米力农在充血性心力衰竭治疗中的疗效及安全性[J]. 中国医药指南, 2013, 11(3): 152-153. FENG Yongmeng, GUO Ruixia, ZHANG Feifei. Different dose of milrinone in the treatment of congestive heart failure efficacy and safety [J]. Guide to Chinese Medicine, 2013, 11(3):152-153.
[9] Birger A, Mikael A, Anders M, et al. Milrinone improves dias-tolic function in coronary artery bypass surgery as assessed by acoustic quantification and peak filling rate: a prospective randomized study[J]. J Cardiothorac Vasc Anesth, 2010, 24(2):244-249.
[10] Lee J, Kim GB, Kwon HW, et al. Safety and efficacy of the off-label use of milrinone in pediatric with heart desases[J] Korean Circ J, 2014, 44(5):320-327.
[11] Mc Namara PJ, Laique F, Muang-In S, et al. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn[J]. J Crit Care, 2006, 21(2):217-222.
[12] Lakshminrusimha S, Porta NF, Farrow KN, et al. Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn[J]. Pediatr Crit Care Med, 2009, 10(1):106-112.
[13] Faraday N. Perioperative platelet activation and the inhibitory effect of milrinone[J]. Anesthesiology, 2009, 111(6):1185-1186.
[14] Lamarche Y, Malo O, Thorin E, et al. Inhalde but not ineravenous milrinong prevents pulmonary endothelial dysfunction after cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg, 2005, 130(1):83-92.
[1] 申路佳,逯天威,巩伟明,赵岩松,王淑康,袁中尚. 代谢风险评分在2型糖尿病人群心血管结局预测中的应用[J]. 山东大学学报 (医学版), 2025, 63(8): 69-78.
[2] 贾魁,李治国,程翠婷,李志娟,刘瑞卿. 银杏叶片联合曲美他嗪治疗老年慢性心力衰竭的效果及机制[J]. 山东大学学报 (医学版), 2025, 63(6): 19-26.
[3] 葛雪,赵红艳. 疱疹病毒感染对重症肺炎患者临床预后及呼吸道微生态的影响[J]. 山东大学学报 (医学版), 2025, 63(6): 27-37.
[4] 李敬,郝盼盼. 急性心力衰竭患者出入院心率变化与预后相关性[J]. 山东大学学报 (医学版), 2025, 63(4): 75-82.
[5] 刘文钊,张远,马湘萍,魏峰涛,卜培莉. 内皮活化和应激指数预测值与心力衰竭患者死亡风险的关联[J]. 山东大学学报 (医学版), 2025, 63(11): 27-35.
[6] 张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61.
[7] 赵子辉,王旭阳,张鹏,方宁宁,石端博,杨帆,杨晓玫,吴剑波. 经膈肌穿刺法快速准确评估大鼠肺动脉高压[J]. 山东大学学报 (医学版), 2024, 62(2): 20-28.
[8] 董雪,赵霞,程子捷,韩毅. 左西孟旦和米力农治疗重症心力衰竭合并肾损伤患者711例的药物经济学评价[J]. 山东大学学报 (医学版), 2022, 60(4): 91-98.
[9] 高燕,朱庆颖,栾明亚,刘科卫. 托伐普坦联合达格列净对心衰大鼠心肌纤维化的影响[J]. 山东大学学报 (医学版), 2022, 60(12): 13-18.
[10] 曾媛媛,杨东鹏,董柱,张本,曹一秋,王晓武. 川芎嗪对野百合碱诱导大鼠肺动脉高压的影响及机制[J]. 山东大学学报 (医学版), 2022, 60(11): 63-69.
[11] 范晓艳,王元耕,陈泽涛. 黄芪桂枝五物汤治疗心衰的网络药理学机制[J]. 山东大学学报 (医学版), 2022, 60(11): 70-81.
[12] 兰洪涛,贾旭,童洲杰,郑曼,胡伯昂,钟明,张薇,王志浩. 无选择性152例成年慢性心力衰竭患者再入院的危险因素[J]. 山东大学学报 (医学版), 2021, 59(4): 63-69.
[13] 安袁笑雪,赵玉英,赵翠芬,许瑞英,薛玉文. 合并型甲基丙二酸血症并发肺动脉高压2例并文献复习[J]. 山东大学学报 (医学版), 2021, 59(10): 103-109.
[14] 温鹏,董亮,王欣,魏敏,刘岩,徐玉荣,孙文青,周明香. 重症新型冠状病毒肺炎1例并文献复习[J]. 山东大学学报 (医学版), 2020, 58(3): 58-61.
[15] 张淑莹,武晓峰,郭丽敏,乔温,彭洁琼,李大庆. 两种阿霉素心力衰竭模型及心功能进展的评估[J]. 山东大学学报 (医学版), 2020, 58(12): 1-7.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!